| Moxibustion for Mild and Moderate Ulcerative Colitis (NCT02084186) | Shanghai Institute of Acupuncture, Moxibustion and Meridian | 2014-03-01 |
| Effects of WB-EMS in Ulcerative Colitis Patients (NCT02144129) | University of Erlangen-Nürnberg Medical School | 2014-03-01 |
| Development of 'Emma'--a Pediatric IBD Quiz (NCT02065089) | Mayo Clinic | 2014-02-06 |
| Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease (NCT02057016) | Catholic University of the Sacred Heart | 2014-02-01 |
| Fecal Microbiota Transplantation (FMT) for Treatment of Ulcerative Colitis in Children (NCT01947101) | Baylor College of Medicine | 2014-02-01 |
| The Effect of VSL#3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease (NCT01765439) | Charles University, Czech Republic | 2014-02-01 |
| Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease (NCT02054533) | Icahn School of Medicine at Mount Sinai | 2014-02-01 |
| Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases (NCT01988506) | Assistance Publique - Hôpitaux de Paris | 2014-01-06 |
| Effects of Eicosapentaenoic Acid on Subjects at High Risk for Colorectal Cancer (NCT02069561) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2014-01-01 |
| Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease (NCT02066272) | Maria Sklodowska-Curie National Research Institute of Oncology | 2014-01-01 |
| Anti-Inflammatory Effects of Mango Polyphenolics in Inflammatory Bowel Disease (NCT02227602) | Texas A&M University | 2014-01-01 |
| Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn's Disease (NCT01891214) | Rennes University Hospital | 2013-12-01 |
| Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel Diseases (NCT02020382) | Assistance Publique - Hôpitaux de Paris | 2013-12-01 |
| MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients (NCT01959165) | AstraZeneca | 2013-11-21 |
| Faecal Microbiota Transplantation in Ulcerative Colitis (NCT01896635) | The University of New South Wales | 2013-11-01 |
| Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis (NCT03268213) | Stony Brook University | 2013-11-01 |
| Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort (NCT02502552) | Centre Hospitalier Universitaire de Saint Etienne | 2013-11-01 |
| Metabolomic Markers of Fatigue in Inflammatory Bowel Disease (NCT04191707) | Corporacion Parc Tauli | 2013-11-01 |
| Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease (NCT01861288) | Herlev Hospital | 2013-11-01 |
| The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients (NCT01916161) | National Health Service, United Kingdom | 2013-10-01 |
| Fecal Microbiota Transplantation in Patients With Ulcerative Colitis (NCT01961492) | Turku University Hospital | 2013-10-01 |
| The Canadian Children Inflammatory Bowel Disease Network (CIDsCaNN) (NCT02308917) | The Hospital for Sick Children | 2013-09-01 |
| Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease (NCT01860651) | Hvidovre University Hospital | 2013-09-01 |
| TP0502-B-Pharmaco-Scintigraphic-Study (NCT02306798) | Tillotts Pharma AG | 2013-09-01 |
| Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound (NCT01852760) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2013-09-01 |
| Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis (NCT01941589) | Sheba Medical Center | 2013-09-01 |
| Special Investigation in Patients With Ulcerative Colitis (NCT01947816) | AbbVie | 2013-08-09 |
| Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Inactive UC Patients (NCT01929668) | Kyungpook National University Hospital | 2013-08-01 |
| Study of Freeze-dried Black Raspberry in Maintenance of Ulcerative Colitis (NCT02267694) | UConn Health | 2013-08-01 |
| Hyperbaric Oxygen for Ulcerative Colitis (NCT02144350) | Dartmouth-Hitchcock Medical Center | 2013-08-01 |
| Responsiveness of Endoscopic Evaluation in UC (NCT01960439) | University of Western Ontario, Canada | 2013-07-01 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| Self-Management Assistance for Recommended Treatment (SMART) Portal (NCT01966744) | Children's Hospital Medical Center, Cincinnati | 2013-07-01 |
| Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC) (NCT01861249) | Sanofi | 2013-07-01 |
| A Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative Colitis (NCT02058524) | University of Chicago | 2013-06-01 |
| Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis (NCT01914887) | Instituto de Investigación Hospital Universitario La Paz | 2013-06-01 |
| Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC) (NCT01716039) | Alimentiv Inc. | 2013-06-01 |
| HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative Colitis (NCT01882764) | Hutchison Medipharma Limited | 2013-06-01 |
| Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease (NCT02073526) | Oslo University Hospital | 2013-05-01 |
| Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC) (NCT03689673) | Ipsen | 2013-04-24 |
| Gastrointestinal Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit (NCT01745029) | University of Aarhus | 2013-04-01 |
| Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis (NCT01829321) | Lakefront Biotherapeutics NV | 2013-04-01 |
| Ulcerative Colitis and Vitamin D Supplementation (NCT01846026) | University Hospital of North Norway | 2013-04-01 |
| Gastrointestinal Transit Times and Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit (NCT01752361) | University of Aarhus | 2013-04-01 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis (NCT01831427) | Gilead Sciences | 2013-03-28 |
| Long-Term Safety Of PF-00547659 In Ulcerative Colitis (NCT01771809) | Shire | 2013-03-18 |
| Predictors of Prognosis in IBD Patients (NCT05653011) | Seoul National University Bundang Hospital | 2013-03-11 |
| Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease (NCT01810185) | Santa Barbara Cottage Hospital | 2013-03-01 |
| A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis (NCT01805791) | Hutchison Medipharma Limited | 2013-03-01 |
| Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice (NCT01768858) | AbbVie | 2013-02-05 |
| Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis (NCT01759056) | Avaxia Biologics, Incorporated | 2013-02-01 |
| Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease (NCT02128503) | Chinese University of Hong Kong | 2013-02-01 |
| Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative Proctitis (NCT01837615) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2013-01-01 |
| A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis (NCT01839214) | Vascular Biogenics Ltd. operating as VBL Therapeutics | 2013-01-01 |
| Effect of FAn-7 in UC Activity (NCT01771224) | National Institute of Medical Sciences and Nutrition, Salvador Zubiran | 2013-01-01 |
| Granulocyte-monocyte Apheresis in Ulcerative Colitis (NCT03189888) | Valduce Hospital | 2013-01-01 |
| Efficacy and Safety Study of Ozanimod in Ulcerative Colitis (NCT01647516) | Celgene | 2012-12-26 |
| The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation, Endothelial Function, and Markers of Inflammation (NCT01078935) | The Baruch Padeh Medical Center, Poriya | 2012-12-01 |
| Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea. (NCT01731665) | Asan Medical Center | 2012-12-01 |
| Use of Rectal Dialysis Technique to Measure Rectal 5-ASA Levels in Healthy Volunteers Receiving Asacol (NCT04032652) | Endeavor Health | 2012-12-01 |
| Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis (NCT01694485) | Amgen | 2012-11-16 |
| A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis (NCT01620255) | Shire | 2012-11-02 |
| A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis (NCT01706159) | Novo Nordisk A/S | 2012-10-01 |
| Multimodal Approach in IBD Patients (NCT01705522) | Clinical Hospital Colentina | 2012-10-01 |
| TP0502-Pharmaco-Scintigraphic-Study and Amendment (NCT02306785) | Tillotts Pharma AG | 2012-10-01 |
| Fecal Microbiota Transplantation for Ulcerative Colitis (NCT01742754) | University of Washington | 2012-10-01 |
| Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis (NCT01418131) | The University of Western Australia | 2012-10-01 |
| Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis (NCT01470612) | Pfizer | 2012-10-01 |
| Photodynamic Therapy for Ulcerative Colitis (NCT01697670) | University of Zurich | 2012-09-01 |
| Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD) (NCT01692743) | University of Maryland, Baltimore | 2012-09-01 |
| Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA (NCT01654783) | Kyorin Pharmaceutical Co.,Ltd | 2012-09-01 |
| FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD) (NCT01676324) | University of British Columbia | 2012-09-01 |
| Immune Modulation From Trichuris Suis (NCT03079700) | University of Aarhus | 2012-08-01 |
| Efficacy of Gralise® for Chronic Pelvic Pain (NCT01678911) | Shirley Ryan AbilityLab | 2012-08-01 |
| Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis (NCT01659138) | Sanofi | 2012-08-01 |
| Adalimumab in the Treatment of Chronic Pouchitis (NCT01670240) | Odense University Hospital | 2012-08-01 |
| Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative Colitis (NCT01783119) | National Institute of Medical Sciences and Nutrition, Salvador Zubiran | 2012-08-01 |
| Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC) (NCT01678300) | Beth Israel Deaconess Medical Center | 2012-08-01 |
| A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis (NCT01458574) | Pfizer | 2012-07-20 |
| Predicting Response to Standardized Pediatric Colitis Therapy (NCT01536535) | Connecticut Children's Medical Center | 2012-07-10 |
| Vitamin D Treatment in Ulcerative Colitis (NCT01640496) | University of Chicago | 2012-07-01 |
| Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis (NCT01612039) | Telsar Pharma Inc. | 2012-07-01 |
| A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis (NCT01458951) | Pfizer | 2012-06-01 |
| Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis (NCT01586533) | Altheus Therapeutics, Inc. | 2012-06-01 |
| A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160) (NCT01562314) | GW Research Ltd | 2012-05-09 |
| Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs (NCT01387594) | Shire | 2012-05-03 |
| High Definition Versus Chromoendoscopy for Dysplasia Detection in Ulcerative Colitis (UC) (NCT02138318) | The Leeds Teaching Hospitals NHS Trust | 2012-05-01 |
| A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting (NCT01550965) | AbbVie (prior sponsor, Abbott) | 2012-05-01 |
| A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis (NCT01465763) | Pfizer | 2012-04-01 |
| A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis (NCT01551290) | Xian-Janssen Pharmaceutical Ltd. | 2012-04-01 |
| Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis (NCT01538251) | sigma-tau i.f.r. S.p.A. | 2012-04-01 |
| Endoscopy and Endomicroscopy for Assessment of Mucosal Healing in Inflammatory Bowel Disease (IBD) (NCT01524120) | University of Erlangen-Nürnberg Medical School | 2012-04-01 |
| Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis (NCT01482884) | AstraZeneca | 2012-03-01 |
| Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis (NCT01545908) | Hamilton Health Sciences Corporation | 2012-03-01 |
| Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis (NCT01506362) | BioLineRx, Ltd. | 2012-03-01 |
| The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID (NCT02135289) | Chinese University of Hong Kong | 2012-03-01 |
| Improving Medication Adherence in Pediatric Inflammatory Bowel Disease (NCT01536509) | Children's Hospital Medical Center, Cincinnati | 2012-02-01 |
| Mesalazine (PENTASA®) in Ulcerative Colitis (NCT01517607) | Ferring Pharmaceuticals | 2012-02-01 |
| Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (NCT01393405) | University of North Carolina, Chapel Hill | 2012-02-01 |
| A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis (NCT01456052) | Lexicon Pharmaceuticals | 2012-01-30 |